Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY

Benzinga Newsdesk www.benzinga.com Negative 56.3%

Neg 56.3% Neu 0% Pos 0%

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.09) per share. This is a 88.16 percent increase over losses of $(0.76) per share from the same period last year. The company reported $6.406 million in sales this quarter. This is a 59.55 percent increase over sales of $4.015 million the same period last year.